Outputs (14)

The incidence of metabolic syndrome amongst a group of migrants to Qatar employed in Hamad Medical Corporation 24 months post-migration: a prospective longitudinal observational cohort study. (2022)
Thesis
EZZAT AHMED AL-ADAWY, R.M.M. 2022. The incidence of metabolic syndrome amongst a group of migrants to Qatar employed in Hamad Medical Corporation 24 months post-migration: a prospective longitudinal observational cohort study. Robert Gordon University, PhD thesis. Hosted on OpenAIR [online]. Available from: https://doi.org/10.48526/rgu-wt-1880237

Over the past two decades, the International Organisation for Migration highlighted the increasing proportion of international migration from 2.8% (150 million in 2000) to 3.5% (272 million in 2020) of the total world population. In 2019, the Labour... Read More about The incidence of metabolic syndrome amongst a group of migrants to Qatar employed in Hamad Medical Corporation 24 months post-migration: a prospective longitudinal observational cohort study..

The incidence and determinants of metabolic syndrome amongst a group of migrants to Qatar: a prospective longitudinal observational cohort study 24-months post-migration. (2021)
Journal Article
AL-ADAWI, R.M., PRABHU, K.S., STEWART, D., RYAN, C., ABDELAZIZ, H., ELEDRISI, M., IBRAHIM, M.I.M., UDDIN, S. and TONNA, A.P. 2022. The incidence and determinants of metabolic syndrome amongst a group of migrants to Qatar: a prospective longitudinal observational cohort study 24-months post-migration. Journal of clinical medicine [online], 11(1), article 34. Available from: https://doi.org/10.3390/jcm11010034

While there is some evidence that migration to Western countries increases metabolic syndrome (MetS) risk, there is a lack of data pertaining to migration to the Middle East. This study aimed to investigate the relationship between migration and MetS... Read More about The incidence and determinants of metabolic syndrome amongst a group of migrants to Qatar: a prospective longitudinal observational cohort study 24-months post-migration..

The incidence of metabolic syndrome amongst Qatar migrants 24 months post-migration: a prospective longitudinal observational cohort study. (2021)
Presentation / Conference
AL-ADAWI, R., PRABHU, K.S., RYAN, C., ABDELAZIZ, H., EL EDRISI, M. and IBRAHIM, M.I.M. 2021. The incidence of metabolic syndrome amongst Qatar migrants 24 month post-migration: a prospective longiudinal observational cohort study. Presented at 49th ESCP (European Society of Clinical Pharmacy) virtual symposium on clinical pharmacy (ESCP 2021): clinical pharmacy, working collaboratively in mental health care, 19-21 October 2021, [virtual conference].

Background and Objective: Evidence indicates that migration to Western countries is associated with increased metabolic syndrome (MetS) risk. There is, however, a scarcity of data about MetS incidence in migrants to Middle Eastern countries. This stu... Read More about The incidence of metabolic syndrome amongst Qatar migrants 24 months post-migration: a prospective longitudinal observational cohort study..

Incidence of co-trimoxazole-induced hyperkalemia in a tertiary care hospital. (2021)
Journal Article
AL ADAWI, R.M., ALBU-MAHMOOD, Z., ABDELGELIL, M., ABDELAZIZ, H., STEWART, D. and AWAISU, A. 2021. Incidence of co-trimoxazole-induced hyperkalemia in a tertiary care hospital. Risk management and healthcare policy [online], 14, pages 519-525. Available from: https://doi.org/10.2147/RMHP.S283471

Co-trimoxazole is a broad-spectrum antibiotic associated with hyperkalemia. To determine the incidence of hyperkalemia and its risk factors in patients receiving co-trimoxazole. A retrospective observational study involving all patients who received... Read More about Incidence of co-trimoxazole-induced hyperkalemia in a tertiary care hospital..

A systematic review of pharmacists’ input in the screening, management and prevention of metabolic syndrome. (2020)
Presentation / Conference
AL ADAWI, R., STEWART, D., RYAN, C. and TONNA, A. 2020. A systematic review of pharmacists' input in the screening, management and prevention of metabolic syndrome. Presented at Qatar University Annual Research Forum and Exhibition 2020 (QUARFE 2020), 28 October 2020,Doha, Qatar. Hosted on Qspace [online]. Available from: https://doi.org/10.29117/quarfe.2020.0152

To critically appraise, synthesise, and present the available evidence on pharmacists' input to the screening, prevention and management of metabolic syndrome (MetS). The protocol was developed based on the 'Preferred Reporting Items for Systematic r... Read More about A systematic review of pharmacists’ input in the screening, management and prevention of metabolic syndrome..

A systematic review of pharmacist input to metabolic syndrome screening, management and prevention. (2020)
Journal Article
AL ADAWI, R.M., STEWART, D., RYAN, C. and TONNA, A. 2020. A systematic review of pharmacist input to metabolic syndrome screening, management and prevention. International journal of clinical pharmacy [online], 42(4), pages 995-1015. Available from: https://doi.org/10.1007/s11096-020-01084-3

Metabolic syndrome is a cluster of factors that increase the risk of cardiovascular disease and include: diabetes and prediabetes, abdominal obesity, elevated triglycerides, low high-density lipoprotein cholesterol and high blood-pressure. However, t... Read More about A systematic review of pharmacist input to metabolic syndrome screening, management and prevention..

Evaluating the effectiveness of pneumococcal vaccines against hospitalization and intensive care unit admission in adults. (2019)
Journal Article
EL-BARDISSY, A.H.E., AL-ADAWI, R.M., SHIBLE, A.A., ALBU-MAHMOOD, Z., ELGAILY, D.E. and ABDELAZIZ, H. 2019. Evaluating the effectiveness of pneumococcal vaccines against hospitalization and intensive care unit admission in adults. Journal of pharmaceutical health services research [online], 10(4), pages 427-431. Available from: https://doi.org/10.1111/jphs.12321

Objective: To evaluate the efficacy of pneumococcal vaccines concerning hospital or intensive care unit (ICU) admissions due to pneumonia after vaccination. Setting: Inpatient and ICUs at Hamad General Hospital. Methods: The retrospective study inclu... Read More about Evaluating the effectiveness of pneumococcal vaccines against hospitalization and intensive care unit admission in adults..

Critical appraisal of the clinical practice guideline for the management of dyslipidaemia and prevention of cardiovascular disease: AACE 2017 guidelines. (2019)
Journal Article
ALKHAWAJA, R.M., MADI, L., ALHAMOUD, E., ABDALLAH, I., JAVED, M., FAYEZ, H. and AL-ADAWI, R.M. 2019. Critical appraisal of the clinical practice guideline for the management of dyslipidaemia and prevention of cardiovascular disease: AACE 2017 guidelines. Journal of pharmaceutical health services research [online], 10(3), pages 383-388. Available from: https://doi.org/10.1111/jphs.12302

Objective: This study aims to appraise 2017 AACE Guidelines for Management of Dyslipidemia and Prevention of Cardiovascular Disease by using Appraisal of Guidelines for Research and Evaluation II (AGREE II) tool. Method: A total of seven investigator... Read More about Critical appraisal of the clinical practice guideline for the management of dyslipidaemia and prevention of cardiovascular disease: AACE 2017 guidelines..

Assessment of dapagliflozin effectiveness as add-on therapy for the treatment of type 2 diabetes mellitus in a Qatari population. (2019)
Journal Article
AL ADAWI, R.M., JASSIM, Z., ELGAILY, D., ABDELAZIZ, H., SREE, B. and MOHAMED IBRAHIM, M.I. 2019. Assessment of dapagliflozin effectiveness as add-on therapy for the treatment of type 2 diabetes mellitus in a Qatari population. Scientific reports [online], 9, article 6864. Available from: https://doi.org/10.1038/s41598-019-43052-6

The effectiveness of dapagliflozin in the management of type-2 diabetes mellitus (T2-DM) is an essential issue for establishing a basis for prescribing dapagliflozin. This study aimed to assess the effectiveness of dapagliflozin in combination with o... Read More about Assessment of dapagliflozin effectiveness as add-on therapy for the treatment of type 2 diabetes mellitus in a Qatari population..

Twice-daily insulin glargine for patients with uncontrolled type 2 diabetes mellitus. (2018)
Journal Article
ELEDRISI, M., SULEIMAN, N.N., SALAMEH, O., HAMAD, M.K., RABADI, O., MOHAMED, A., AL ADAWI, R. and SALAM, A. 2019. Twice-daily insulin glargine for patients with uncontrolled type 2 diabetes mellitus. Journal of clinical and translational endocrinology [online], 15, pages 35-36. Available from: https://doi.org/10.1016/j.jcte.2018.12.002

Insulin glargine is recombinant human insulin analog that is commonly used in patients with type 2 diabetes as well as those with type 1 diabetes. Pharmacokinetic and pharmacodynamics studies of insulin glargine had shown that it has an onset of acti... Read More about Twice-daily insulin glargine for patients with uncontrolled type 2 diabetes mellitus..